Common variable immunodeficiency: The power of co-stimulation

Seminars in Immunology

Volumn 18, Issue 6, 2006, Pages 337-346

  Salzer, Ulrich ^a   Grimbacher, Bodo ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

B cells; CD19; CVID; ICOS; Immunodeficiency; TACI

Indexed keywords

ANTIMALARIAL AGENT; CAPTOPRIL; CARBAMAZEPINE; CD19 ANTIGEN; CORTICOSTEROID; FENCLOFENAC; GLUCOCORTICOID; ICOS PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYTOIN; PNEUMOCOCCUS VACCINE; PROTEIN DERIVATIVE; SALAZOSULFAPYRIDINE; TACI PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTHRITIS; AUTOIMMUNITY; B LYMPHOCYTE; BONE DISEASE; CELL DIFFERENTIATION; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE COURSE; GERMINAL CENTER; GRANULOMA; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPOGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PHENOTYPE; REVIEW; SARCOIDOSIS; T LYMPHOCYTE;

ANIMALS; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS;

EID: 33749438096     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2006.07.004     Document Type: Review

References (132)

1. Conley M.E., Broides A., Hernandez-Trujillo V., Howard V., Kanegane H., Miyawaki T., et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203 (2005) 216-234
2. Conley M.E. Early defects in B cell development. Curr Opin Allergy Clin Immunol 2 (2002) 517-522
3. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 (1993) 990-993
4. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., and de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 541-543
5. Ferrari S., Giliani S., Insalaco A., Al-Ghonaium A., Soresina A.R., Loubser M., et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98 (2001) 12614-12619
6. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575
7. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4 (2003) 1023-1028
8. Buck D., Malivert L., de Chasseval R., Barraud A., Fondaneche M.C., Sanal O., et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124 (2006) 287-299
9. www.esid.org
10. IUIS. Primary immunodeficiency diseases. Report of an IUIS Scientific committee. International Union of Immunological Societies. Clin Exp Immunol 1999;118(Suppl. 1):1-28.
11. Hammarstrom L., Vorechovsky I., and Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120 (2000) 225-231
12. Hermaszewski R.A., and Webster A.D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86 (1993) 31-42
13. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92 (1999) 34-48
14. Carsetti R., Rosado M.M., Donnanno S., Guazzi V., Soresina A., Meini A., et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 115 (2005) 412-417
15. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104 (2004) 3647-3654
16. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197 (2003) 939-945
17. Hammarstroem L., and Smith C.I.E. Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs H.D., Smith C.I.E., and Puck J.M. (Eds). Primary immunodeficiency diseases: a molecular and genetic approach (2001), Oxford University Press, New York, NY 250-262
18. Washington K., Stenzel T.T., Buckley R.H., and Gottfried M.R. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20 (1996) 1240-1252
19. Sordet C., Cantagrel A., Schaeverbeke T., and Sibilia J. Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine 72 (2005) 503-514
20. Bonilla H.F., Chenoweth C.E., Tully J.G., Blythe L.K., Robertson J.A., Ognenovski V.M., et al. Mycoplasma felis septic arthritis in a patient with hypogammaglobulinemia. Clin Infect Dis 24 (1997) 222-225
21. Steuer A., Franz A., Furr P.M., Taylor-Robinson D., Webster A.D., and Hughes G.R. Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis. J Infect 33 (1996) 235-237
22. Kaczmarski R.S., Webster A.D., Moxham J., Davison F., Sutherland S., and Mufti G.J. CD4+ lymphocytopenia due to common variable immunodeficiency mimicking AIDS. J Clin Pathol 47 (1994) 364-366
23. Medlicott S.A., Coderre S., Horne G., and Panaccione R. Multimodal immunosuppressant therapy in steroid-refractory common variable immunodeficiency sprue: a case report complicating cytomegalovirus infection. Int J Surg Pathol 14 (2006) 101-106
24. Wang J., and Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 25 (2005) 57-62
25. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev 16 (2002) 61-64
26. Knight A.K., and Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5 (2006) 156-159
27. Michel M., Chanet V., Galicier L., Ruivard M., Levy Y., Hermine O., et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 83 (2004) 254-263
28. Vorechovsky I., Webster A.D., Plebani A., and Hammarstrom L. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 64 (1999) 1096-1109
29. Kralovicova J., Hammarstrom L., Plebani A., Webster A.D., and Vorechovsky I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol 170 (2003) 2765-2775
30. Gompels M.M., Hodges E., Lock R.J., Angus B., White H., Larkin A., et al. Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol 134 (2003) 314-320
31. Mechanic L., Dikman S., and Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127 (1997) 613-617
32. Bates C.A., Ellison M.C., Lynch D.A., Cool C.D., Brown K.K., and Routes J.M. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 114 (2004) 415-421
33. Mullighan C.G., Fanning G.C., Chapel H.M., and Welsh K.I. TNF and lymphotoxin alpha polymorphisms associated with common variable immunodeficiency: Role in the pathogenesis of granulomatous disease. J Immunol 159 (1997) 6236-6241
34. Wheat W.H., Cool C.D., Morimoto Y., Rai P.R., Kirkpatrick C.H., Lindenbaum B.A., et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 202 (2005) 479-484
35. Warnatz K., Bossaller L., Salzer U., Skrabl-Baumgartner A., Schwinger W., van der Burg M., et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107 (2006) 3045-3052
36. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37 (2005) 820-828
37. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 (2005) 829-834
38. Liu Y.J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106 (2001) 259-262
39. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent Immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 (2002) 822-829
40. Poeck H., Wagner M., Battiany J., Rothenfusser S., Wellisch D., Hornung V., et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103 (2004) 3058-3064
41. He B., Quiao X., and Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 173 (2004) 4479-4491
42. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Galicier L., Lepelletier Y., Webster D., et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104 (2004) 2441-2443
43. Scott-Taylor T.H., Green M.R., Eren E., and Webster A.D. Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin Exp Immunol 138 (2004) 484-490
44. Cunningham-Rundles C., and Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 115 (2005) 147-153
45. Viallard J.F., Camou F., Andre M., Liferman F., Moreau J.F., Pellegrin J.L., et al. Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Therapy 7 (2005) R1052-R1055
46. Cunningham-Rundles C., Radigan L., Knight A.K., Zang L., Bauer L., and Nakazawa A. TLR9 activation is defective in common variable immunodeficiency. J Immunol 176 (2006) 1978-1987
47. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
48. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299 (2003) 2076-2079
49. Day N., Tangsinmankong H., Ochs H., Rucker R., Picard C., Casanova J.L., et al. Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses. J Pediatr 144 (2004) 524-526
50. North M.E., Webster A.D., and Farrant J. Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia. Clin Exp Immunol 81 (1990) 412-416
51. Fischer M.B., Hauber I., Vogel E., Wolf H.M., Mannhalter J.W., and Eibl M.M. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol 92 (1993) 340-352
52. Ferrer J.M., Iglesias J., Hernandez M., and Matamoros N. Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients. Clin Exp Immunol 102 (1995) 286-289
53. Holm A.M., Aukrust P., Aandahl E.M., Muller F., Tasken K., and Froland S.S. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency-involvement of protein kinase A type I. J Immunol 170 (2003) 5772-5777
54. Holm A.M., Aukrust P., Damas J.K., Muller F., Halvorsen B., and Froland S.S. Abnormal interleukin-7 function in common variable immunodeficiency. Blood 105 (2005) 2887-2890
55. Fischer M.B., Hauber I., Eggenbauer H., Thon V., Vogel E., Schaffer E., et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood 84 (1994) 4234-4241
56. Fischer M.B., Wolf H.M., Hauber I., Eggenbauer H., Thon V., Sasgary M., et al. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 26 (1996) 231-237
57. Boncristiano M., Majolini M.B., D'Elios M.M., Pacini S., Valensin S., Ulivieri C., et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 30 (2000) 2632-2638
58. Paccani S.R., Boncristiano M., Patrussi L., Ulivieri C., Wack A., Valensin S., et al. Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood 106 (2005) 626-634
59. Farrington M., Grosmaire L.S., Nonoyama S., Fischer S.H., Hollenbaugh D., Ledbetter J.A., et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 91 (1994) 1099-1103
60. Pozzi N., Gaetaniello L., Martire B., De Mattia D., Balestrieri B., Cosentini E., et al. Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 123 (2001) 99-104
61. Nordoy I., Muller F., Aukrust P., and Froland S.S. Adhesion molecules in common variable immunodeficiency (CVID)-a decrease in l-selectin-positive T lymphocytes. Clin Exp Immunol 114 (1998) 258-263
62. Denz A., Eibel H., Illges H., Kienzle G., Schlesier M., and Peter H.H. Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients. Eur J Immunol 30 (2000) 1069-1077
63. Groth C., Drager R., Warnatz K., Wolff-Vorbeck G., Schmidt S., Eibel H., et al. Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 129 (2002) 133-139
64. Brouet J.C., Chedeville A., Fermand J.P., and Royer B. Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 30 (2000) 2516-2520
65. Agematsu K., Futatani T., Hokibara S., Kobayashi N., Takamoto M., Tsukada S., et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 103 (2002) 34-42
66. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99 (2002) 1544-1551
67. Piqueras B., Lavenu-Bombled C., Galicier L., Bergeron-van der Cruyssen F., Mouthon L., Chevret S., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23 (2003) 385-400
68. Ko J., Radigan L., and Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 116 (2005) 37-41
69. Bonhomme D., Hammarstrom L., Webster D., Chapel H., Hermine O., Le Deist F., et al. Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 165 (2000) 4725-4730
70. Andersen P., Permin H., Andersen V., Schejbel L., Garred P., Svejgaard A., et al. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 105 (2005) 511-517
71. Schejbel L., Marquart H., Andersen V., Permin H., Andersen P., Svejgaard A., et al. Deficiency of somatic hypermutation of Immunoglobulin G transcripts is a better predictor of severe respiratory tract infection than lack of memory B cells in common variable immunodeficiency. J Clin Immunol 25 (2005) 392-403
72. Taubenheim N., von Hornung M., Durandy A., Warnatz K., Corcoran L., Peter H.H., et al. Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients. J Immunol 175 (2005) 5498-5503
73. Cuss A.K., Avery D.T., Cannons J.L., Yu L.J., Nichols K.E., Shaw P.J., et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 176 (2006) 1506-1516
74. Warnatz K., Salzer U., Gutenberger S., Bossaller L., Schlesier M., and Grimbacher B. Finally found: human BAFF-R Deficiency causes CVID. XIth Meeting for the European Society for Immunodeficiencies (2004) 72 [abstract #B]
75. Vorechovsky I., Zetterquist H., Paganelli R., Koskinen S., Webster A.D., et al. Family and Linkage study of selcetive IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 77 (1995) 185-192
76. Burrows P.D. Cooper MD IgA deficiency. Adv Immunol 65 (1997) 245-276
77. Eastwood D., Gilmour K.C., Nistala K., Meaney C., Chapel H., Sherrell Z., et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 137 (2004) 584-588
78. Weston S.A., Prasad M.L., Mullighan C.G., Chapel H., and Benson E.M. Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?. Clin Exp Immunol 124 (2001) 465-469
79. Schaffer F.M., Palermos J., Zhu Z.B., Barger B.O., Cooper M.D., and Volanakis J.E. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci USA 86 (1989) 8015-8019
80. Carvalho Neves Forte W., Ferreira De Carvalho Junior F., Damaceno N., Vidal Perez F., Gonzales Lopes C., and Mastroti R.A. Evolution of IgA deficiency to IgG subclass deficiency and common variable immunodeficiency. Allergol Immunopathol 28 (2000) 18-20
81. Jolles S., Tyrer M., Johnson M., and Webster D. Long term recovery of IgG and IgM production during HIV infection in a patient with common variable immunodeficiency (CVID). J Clin Pathol 54 (2001) 713-715
82. Volanakis J.E., Zhu Z.B., Schaffer F.M., Macon K.J., Palermos J., Barger B.O., et al. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodefciency. J Clin Invest 89 (1992) 1914-1922
83. Schroeder Jr. H.W., Zhu Z.B., March R.E., Campbell R.D., Berney S.M., Nedospasov S.A., et al. Susceptibility locus for IgA deficiency and common varibale immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med 4 (1998) 72-86
84. Vorechovsky I., Cullen M., Carrington M., Hammarstrom L., and Webster A.D. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol 164 (2000) 4408-4416
85. Schaffer A.A., Pfannstiel J., Webster A.D., Plebani A., Hammarstrom L., and Grimbacher B. Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q. Hum Genet 118 (2006) 725-729
86. Braig D.U., Schaeffer A.A., Glocker E., Salzer U., Warnatz K., Peter H.H., et al. Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity. Hum Genet 112 (2003) 369-378
87. Finck A., van der Meer J.W., Schäffer A.A., Pfannstiel J., Fieschi C., Plebani A., et al. Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Eur J Hum Genet 14 (2006) 867-875
88. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4 (2003) 261-268
89. van Zelm M.C., Reisli I., van der Burg M., Castano D., van Noesel C.J., van Tol M.J., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354 (2006) 1901-1912
90. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., et al. ICOS is an inducible T-cell co-stimulator, structurally and functionally related to CD28. Nature 397 (1999) 263-266
91. Beier K.C., Hutloff A., Dittrich A.M., Heuck C., Rauch A., Buchner K., et al. Induction, binding specificity and function of human ICOS. Eur J Immunol 30 (2000) 3707-3717
92. Dong C., Juedes A.E., Temann U.A., Shresta S., Allison J.P., Ruddle N.H., et al. ICOS co-stimulatory receptor is essential for T cell activation and function. Nature 409 (2001) 97-101
93. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., et al. ICOS is critical for CD40-mediated antibody class switching. Nature 409 (2001) 102-105
94. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., et al. ICOS is essential for effective T-helper-cell responses. Nature 409 (2001) 105-109
95. Mak T.W., Shahinian A., Yoshinaga S.K., Wakeham A., Boucher L.M., Pintilie M., et al. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell dependent B cell responses. Nat Immunol 4 (2003) 765-772
96. Nurieva R.I., Mai X.M., Forbush K., Bevan M.J., and Dong C. B7h is required for T cell activation, differentiation, and effector function. Proc Natl Acad Sci USA 100 (2003) 14163-14168
97. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., Urschel S., Belohradsky B.H., Litzman J., et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113 (2004) 234-240
98. Ohm-Laursen L., Schjebel L., Jacobsen K., Permin H., Svejgaard A., and Barington T. Normal ICOS, ICOSL and AID alleles in Danish patients with common variable immunodeficiency. Scand J Immunol 61 (2005) 566-574
99. Bossaller L., Burger J., Draeger R., Grimbacher B., Knoth R., Plebani A., et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol 177 (2006) 4927-4932
100. Akiba H., Takeda K., Kojima Y., Usui Y., Harada N., Yamazaki T., et al. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J Immunol 175 (2005) 2340-2348
101. Ebert L.M., Horn M.P., Lang A.B., and Moser B. B cells alter the phenotype and function of follicular-homing CXCR5+ T cells. Eur J Immunol 34 (2004) 3562-3571
102. Lohning M., Hutloff A., Kallinich T., Mages H.W., Bonhagen K., Radbruch A., et al. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 197 (2003) 181-193
103. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 173 (2004) 68-78
104. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
105. Ma C.S., Hare N.J., Nichols K.E., Dupre L., Andolfi G., Roncarolo M.G., et al. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest 115 (2005) 1049-1059
106. Ma C.S., Pittaluga S., Avery D.T., Hare N.J., Maric I., Klion A.D., et al. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J Clin Invest 116 (2006) 322-333
107. Lee W.I., Torgerson T.R., Schumacher M.J., Yel L., Zhu Q., and Ochs H.D. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105 (2005) 1881-1890
108. Novak A.J., Bram R.J., Kay N.E., and Jelinek D.F. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100 (2002) 2973-2979
109. Ng L.G., Sutherland A.P., Newton R., Qian F., Cachero T.G., Scott M.L., et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 173 (2004) 807-817
110. Batten M., Fletcher C., Ng L., Groom J., Wheway J., Laâbi Y., et al. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphomas. J Immunol 172 (2004) 812-822
111. Novak A.J., Darce J.R., Arendt B.K., Harder B., Henderson K., Kindsvogel W., et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 103 (2004) 689-694
112. Moreaux J., Cremer F.W., Reme T., Raab M., Mahtouk K., Kaukel P., et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106 (2005) 1021-1030
113. Jelinek D.F., and Darce J.R. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors. Curr Dir Autoimmun 8 (2005) 266-288
114. Dillon S.R., Gross J.A., Ansell S.M., and Novak A.J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5 (2006) 235-246
115. Mackay F., Sierro F., Grey S.T., and Gordon T.P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 8 (2005) 243-265
116. Castigli E., Wilson S.A., Scott S., Dedeoglu F., Xu S., Lam K.P., et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201 (2005) 35-39
117. Castigli E., Scott S., Dedeoglu F., Bryce P., Jabara H., Bhan A.K., et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 101 (2004) 3903-3908
118. von Bülow G.U., van Deursen J.M., and Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity 14 (2001) 573-582
119. Seshasayee D., Valdez P., Yan M., Dixit V.M., Tumas D., and Grewal I.S. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18 (2003) 279-288
120. Hymowitz S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J., et al. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280 (2005) 7218-7227
121. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201 (2005) 1375-1383
122. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2 (2001) 638-643
123. Tedder T.F. Response-regulators of B lymphocyte signaling thresholds provide a context for antigen receptor signal transduction. Semin Immunol 10 (1998) 259-265
124. Carter R.H., and Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256 (1992) 105-107
125. Tedder T.F., Inaoki M., and Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6 (1997) 107-118
126. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271 (1996) 348-350
127. Wang Y., and Carter R.H. CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity 22 (2005) 749-761
128. Fehr T., Rickert R.C., Odermatt B., Roes J., Rajewsky K., Hengartner H., et al. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J Exp Med 188 (1998) 145-155
129. Rickert R.C., Rajewsky K., and Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376 (1995) 352-355
130. Wardemann H., Boehm T., Dear N., and Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 195 (2002) 771-780
131. Haas K.M., Poe J.C., Steeber D.A., and Tedder T.F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23 (2005) 7-18
132. Fischer A. Human primary immunodeficiency diseases: a perspective. Nat Immunol 5 (2004) 23-30